[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100566557":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":30,"responsibleParty":50,"collaborators":52,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":63,"sex":64,"minAge":65,"maxAge":10,"enrollmentInfo":66,"targetDuration":69,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":75,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Tel-Aviv Sourasky Medical Center","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Healthy subjects",null,"Patients over the age of 40, without active cancer in the last 5 years, who come for a cancer screening (and sometimes other screenings) at the Integrated Cancer Prevention Center",[13],"Other: Blood-based liquid biopsy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"OTHER","Blood-based liquid biopsy","Venous blood sample will be taken from the patient as part of the routine blood tests taken as part of the work at the Medical Center",[9],[21,26],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Nadir Arber, Professor","CONTACT","+972 036973561","nadira@tlvmc.gov.il",{"name":27,"role":23,"phone":28,"phoneExt":10,"email":29},"Shiran Shapira, PhD","+972 526842937","shiran@nano24med.com",[31],{"facility":32,"status":33,"city":34,"state":10,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Integrated Cancer Prevention Center at the Tel Aviv Sourasky Medical Center Ichilov","RECRUITING","Tel Aviv","64239","Israel","IL",{"type":39,"coordinates":40},"Point",[41,42],34.78057,32.08088,{"lat":42,"lon":41},[45,46,48],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},{"name":27,"role":23,"phone":47,"phoneExt":10,"email":29},"+972 0526842937",{"name":22,"role":49,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":51,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[53],{"name":54,"class":16},"Tel Aviv Medical Center","100566557","cancerend24-screening-as-an-aid-to-the-clinician-for-the-diagnosis-of-cancer-100566557",false,"NCT06656728","CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer","Clinical Validation Of A Diagnostic Cancerend24 Screening As An Aid To The Clinician For The Diagnosis Of Cancer In Healthy Subjects Attending The ICPC","CancerenD24","Inclusion Criteria:\n\n1. Completion of all medical exams and questionnaires including cancer diagnoses, demographic data and other epidemiologic information\n2. Willing and able to sign an informed consent\n3. Age ≥40 years\n\nExclusion Criteria:\n\n1. Age \\\u003C 40 years\n2. Pregnancy or breastfeeding\n3. Any type of fever\n4. Any cancer active at study entry or up to 5 years prior to study entry\n5. Polyposis syndromes\n6. Inflammatory bowel disease\n7. Unwilling or unable to provide informed consent",true,"ALL","40 Years",{"count":67,"type":68},2000,"ESTIMATED","36 Months","OBSERVATIONAL","The purpose of the researchers is to test whether the CancerenD24 index, an algorithm based on the quantitative value of CD24, CD11b, clinical and laboratory characteristics, developed in the laboratory can help in the early detection of a malignant disease in a population of healthy subjects.",[73,74],"Cancer","Early Detection of Cancer",[73,76,77,61,78,79,80],"Early detection","Venous blood sample","CD24","CD11b","Malignant disease","2024-10-23",{"date":83,"type":84},"2024-10-24","ACTUAL",{"date":86,"type":84},"2024-09-03",{"date":88,"type":68},"2027-09",{"name":5,"class":6},1]